Brief: Akari Therapeutics Announces Pre-Clinical Development Progress On Long-Acting Pas-Nomacopan

Akari Therapeutics

15/02/2023 13:52

Feb 15 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS ANNOUNCES PRE-CLINICAL DEVELOPMENT
PROGRESS
TOWARD POTENTIAL IND ON LONG-ACTING PAS-NOMACOPAN FOR GEOGRAPHIC
ATROPHY (GA)
    * AKARI THERAPEUTICS ANNOUNCES PRE-CLINICAL DEVELOPMENT
PROGRESS
TOWARD POTENTIAL IND ON LONG-ACTING PAS-NOMACOPAN FOR GEOGRAPHIC
ATROPHY (GA)
    * AKARI THERAPEUTICS PLC- TARGETING AN IND APPLICATION
SUBMISSION
TO U.S. FOOD AND DRUG ADMINISTRATION IN FIRST HALF OF 2024
    * AKARI THERAPEUTICS PLC - TARGETING INVESTIGATIONAL NEW
DRUG
(IND) APPLICATION SUBMISSION TO U.S. FOOD AND DRUG
ADMINISTRATION IN FIRST HALF OF 2024

Source text for Eikon:  ID:nGNXc2ZyFN 
Further company coverage:  AKTX.O 
 ((Reuters.briefs@thomsonreuters.com;))